Franklin Genomic Advancements ETF
Franklin Genomic Advancements ETF (HELX) Covered Calls
Franklin Genomic Advancements ETF trades in the Exchange Traded Fund industry with an IV Rank of 23.02%, low versus the past year. HELX's highest covered call setup is the $44.00 strike expiring Feb 19, 2027, sorted by theoretical annualized return. It's 6.98% out of the money with 95 days to expiration, a 7.34% return until expiration, and a 28.21% theoretical annualized return. Across the setups shown, annualized returns run from 4.39% to 28.21% at strikes between $42.00 and $44.00, with 95 to 186 days to expiration, as of Nov 16, 2026.
Read more
Running HELX covered calls helps you generate income from Franklin Genomic Advancements ETF shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best HELX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If HELX stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling HELX covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given HELX covered call is worth writing.
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.
| 2027-02-19 | 95 | 44.00 | 6.98 | 0.15 | 5.00 | 302.00 | 7.34 | 28.21 | -0.36 | +0.44 | 0 | 4.85 |
| 2027-05-21 | 186 | 44.00 | 6.98 | 0.05 | 5.80 | 292.00 | 7.10 | 13.93 | -0.12 | +0.46 | 0 | 5.75 |
| 2027-02-19 | 95 | 42.00 | 2.12 | 0.15 | 5.80 | 102.00 | 2.48 | 9.53 | -0.36 | +0.52 | 0 | 5.65 |
| 2027-05-21 | 186 | 43.00 | 4.55 | 0.05 | 6.30 | 192.00 | 4.67 | 9.16 | -0.12 | +0.50 | 0 | 6.25 |
| 2027-05-21 | 186 | 42.00 | 2.12 | 0.05 | 6.70 | 92.00 | 2.24 | 4.39 | -0.12 | +0.54 | 0 | 6.65 |
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryExchange Traded Fund
- SectorFinancial
- IV Rank23.02% Low
- Market cap (M$)—
- 52 weeks high-11.12%
- 52 weeks low31.50%
- Analyst recommendation—
- Target price—
- Dividend—
- Payout ratio—
- Earnings date—
- P/E—
- Future P/E—
- EPS (ttm)—
- EPS growth next 5 years—
As of Nov 17, 2026